🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/08/1989 | 12,15 | 12,19 | 11,97 | 12,07 | -0,66% | 1,80% | 3.919.310 |
| 16/08/1989 | 12,07 | 12,15 | 11,97 | 12,15 | +0,83% | 1,48% | 4.844.904 |
| 15/08/1989 | 11,93 | 12,05 | 11,89 | 12,05 | +1,85% | 1,33% | 4.009.858 |
| 14/08/1989 | 11,67 | 11,91 | 11,67 | 11,83 | +1,02% | 2,04% | 3.787.891 |
| 11/08/1989 | 11,85 | 11,95 | 11,69 | 11,71 | -0,51% | 2,18% | 6.652.075 |
| 10/08/1989 | 11,69 | 11,77 | 11,55 | 11,77 | +0,34% | 1,87% | 5.862.931 |
| 09/08/1989 | 11,89 | 11,93 | 11,65 | 11,73 | -1,17% | 2,34% | 3.818.702 |
| 08/08/1989 | 11,87 | 11,97 | 11,85 | 11,87 | -0,50% | 1,00% | 4.179.005 |
| 07/08/1989 | 11,73 | 11,93 | 11,73 | 11,93 | +2,04% | 1,69% | 4.275.840 |
| 04/08/1989 | 11,69 | 11,85 | 11,65 | 11,69 | -1,34% | 1,70% | 4.460.707 |
| 03/08/1989 | 11,95 | 11,95 | 11,79 | 11,85 | -1,00% | 1,33% | 3.337.042 |
| 02/08/1989 | 11,87 | 12,05 | 11,77 | 11,97 | +0,50% | 2,35% | 4.877.602 |
| 01/08/1989 | 12,07 | 12,11 | 11,85 | 11,91 | -1,48% | 2,14% | 5.855.386 |
| 31/07/1989 | 12,15 | 12,17 | 11,91 | 12,09 | -0,33% | 2,13% | 5.083.219 |
| 28/07/1989 | 12,34 | 12,38 | 12,11 | 12,13 | -2,09% | 2,25% | 5.189.486 |
| 27/07/1989 | 12,13 | 12,38 | 12,13 | 12,38 | +2,97% | 2,13% | 5.780.558 |
| 26/07/1989 | 11,71 | 12,05 | 11,69 | 12,03 | +2,54% | 3,06% | 5.095.166 |
| 25/07/1989 | 11,79 | 11,89 | 11,67 | 11,73 | -0,51% | 1,85% | 4.351.296 |
| 24/07/1989 | 11,91 | 11,93 | 11,77 | 11,79 | -1,33% | 1,34% | 4.373.933 |
| 21/07/1989 | 11,65 | 11,99 | 11,65 | 11,95 | +1,52% | 2,90% | 8.117.179 |
| 20/07/1989 | 11,81 | 11,95 | 11,71 | 11,77 | +0,00% | 2,02% | 5.681.208 |
| 19/07/1989 | 11,69 | 11,81 | 11,65 | 11,77 | +1,72% | 1,36% | 5.872.363 |
| 18/07/1989 | 11,43 | 11,65 | 11,41 | 11,57 | +0,52% | 2,09% | 3.610.570 |
| 17/07/1989 | 11,41 | 11,53 | 11,37 | 11,51 | +0,70% | 1,39% | 3.365.966 |
| 14/07/1989 | 11,45 | 11,45 | 11,23 | 11,43 | +0,00% | 1,91% | 4.782.024 |
| 13/07/1989 | 11,41 | 11,49 | 11,39 | 11,43 | -0,17% | 0,87% | 2.490.048 |
| 12/07/1989 | 11,41 | 11,49 | 11,39 | 11,45 | +0,35% | 0,87% | 5.020.968 |
| 11/07/1989 | 11,35 | 11,45 | 11,31 | 11,41 | +1,95% | 1,23% | 6.490.474 |
| 10/07/1989 | 11,25 | 11,29 | 11,15 | 11,19 | -0,35% | 1,24% | 2.835.888 |
| 07/07/1989 | 10,95 | 11,25 | 10,89 | 11,23 | +2,91% | 3,27% | 6.537.634 |